Tirzepatide RESEARCH REFERENCE MATERIAL

BATCH NR: NBLTR107261101

QUALITY TESTING

✓ PURITY
✓ WEIGHT
✓ IDENTITY CONFIRMED (MS + FTIR)

View Certificate of Analysis for this batch →

TIRZEPATIDE — RESEARCH REFERENCE MATERIAL

Test Results
Date Tested: 23.07.2026
Purity (HPLC): 99.3%
Net Weight: 9.94 mg
Molecular Identity (MS): 4813 Da — confirmed
Spectral Identity (FTIR): Confirmed match to reference standard

Overview

Tirzepatide is a synthetic 39-amino-acid peptide compound studied in vitro as a dual agonist at GLP-1 and GIP receptor sites. It is supplied strictly as a laboratory reference standard for use in qualified research settings.

This product is intended solely for in vitro laboratory research and is not formulated, labeled, or approved for human or animal administration.

Molecular Characteristics

Receptor Pharmacology (In Vitro Research Context)

Published in vitro and preclinical literature describes tirzepatide as engaging two receptor systems:

GLP-1 Receptor Binding

• Studied for glucose-dependent modulation of insulin secretion in cell-based assays
• Investigated for effects on glucagon signaling in experimental models

GIP Receptor Binding

• Studied for receptor-level insulin secretion pathways
• Investigated in preclinical models of lipid and energy metabolism signaling

Dual Receptor Engagement

• A subject of ongoing preclinical structure-activity research into combined incretin receptor pharmacology

Handling & Storage

Lyophilized Form Only:

• Store at –20°C
• Protect from light and moisture
• Avoid repeated freeze-thaw cycles
• Handle under standard sterile laboratory technique

This product is shipped and stored exclusively as a lyophilized powder for laboratory use. No reconstitution or administration guidance is provided, as this material is not intended for use outside a controlled research setting.

Research Literature Keywords

• GLP-1 / GIP dual receptor agonist pharmacology
• Incretin receptor binding assays
• Albumin-binding peptide pharmacokinetic modeling
• Structure-activity relationship, incretin peptides

Research Use Disclaimer

This product is intended exclusively for laboratory research by qualified professionals.

• Not for human or veterinary use
• Not for diagnostic or therapeutic use
• Not a drug, supplement, or cosmetic
• Not for internal, topical, or any form of consumption
• Sold only to buyers who confirm appropriate research qualifications

By purchasing this product, the buyer confirms it will be used solely for in vitro laboratory research in accordance with applicable local, national, and international regulations.

Scientific References Peer-reviewed literature on GLP-1/GIP receptor pharmacology, available via PubMed.